1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Gram Negative Infections: new trials by email Literature Review of Gram Negative Infections trials Research Report on Gram Negative Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections Meropenem plus vaborbactam - Gram Negative Infections | Phase 2 | Recruiting | Menarini Group | 44 | 2025-02-18 | 2026-10-07 |
Meropenem (1) · vaborbactam (1)
Menarini Group (1)
Czechia (1) · France (1) · Italy (1) · Poland (1) · Spain (1)